SEC Company Response from Generation Bio Co. (GBIO) (CIK 0001733294) — Jan 4, 2021
Generation Bio Co. (GBIO) (CIK 0001733294)
Date: Jan. 4, 2021 · CIK: 0001733294 · Accession: 0001193125-21-000991
AI Filing Summary & Sentiment
File numbers found in text: 333-251872
Letter
UW Acceleration Request
J.P. Morgan Securities LLC
383 Madison Avenue
New York, New York 10179
Jefferies LLC
520 Madison Avenue
New York, New York 10022
Cowen and Company, LLC
599 Lexington Avenue
New York, New York 10010
January 4, 2021
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C.
Re: Generation Bio Co.
Registration Statement on Form S-1 (File No. 333-251872)
Request for Acceleration of Effective Date
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representatives of the several underwriters, hereby join in the request of Generation Bio Co. (the “Company”) for acceleration of the effective date of the above-named Registration Statement so that it becomes effective at 4:10 PM, Eastern Time, on January 6, 2021, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Wilmer Cutler Pickering Hale and Dorr LLP, request by telephone that such Registration Statement be declared effective.
Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that there will be distributed to each Underwriter or dealer, who is reasonably anticipated to participate in the distribution of the securities, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
We, the undersigned, as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Very truly yours,
Acting severally on behalf of themselves and the several underwriters
Show Raw Text
CORRESP
1
filename1.htm
UW Acceleration Request
J.P. Morgan Securities LLC
383 Madison Avenue
New York, New York 10179
Jefferies LLC
520 Madison Avenue
New York, New York 10022
Cowen and Company, LLC
599 Lexington Avenue
New York, New York 10010
January 4, 2021
VIA EDGAR
U.S. Securities and Exchange Commission
Division
of Corporation Finance
100 F Street, N.E.
Washington, D.C.
20549
Re:
Generation Bio Co.
Registration Statement on Form S-1 (File
No. 333-251872)
Request for Acceleration of Effective Date
Ladies and Gentlemen:
In accordance with Rule 461 under the
Securities Act of 1933, as amended (the “Act”), we, as representatives of the several underwriters, hereby join in the request of Generation Bio Co. (the “Company”) for acceleration of the effective date of the
above-named Registration Statement so that it becomes effective at 4:10 PM, Eastern Time, on January 6, 2021, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Wilmer Cutler Pickering Hale and
Dorr LLP, request by telephone that such Registration Statement be declared effective.
Pursuant to Rule 460 under the Act, we, as representatives of the
several underwriters, wish to advise you that there will be distributed to each Underwriter or dealer, who is reasonably anticipated to participate in the distribution of the securities, as many copies of the proposed form of preliminary prospectus
as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
We, the undersigned, as representatives of the several
underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities
Exchange Act of 1934, as amended.
Very truly yours,
Acting severally on behalf of themselves and the several underwriters
J.P. MORGAN SECURITIES LLC
By:
/s/ David Ke
Name: David Ke
Title: Executive Director
JEFFERIES LLC
By:
/s/ Kevin Sheridan
Name: Kevin Sheridan
Title: Managing Director, Global Joint
Head of Healthcare Investment Banking
COWEN AND COMPANY, LLC
By:
/s/ Bill Follis
Name: Bill Follis
Title: Managing Director
[Signature Page to Underwriters’ Acceleration Request]